– Positive, updated Phase 2 SOLSTICE data showed combination of tobevibart and elebsiran is well tolerated and achieved undetectable HDV RNA in 88% of chronic hepatitis delta participants evaluable at ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness/fitness myths. In my free time I enjoy ...

The city of Aurora is in the early stages of developing various new lending programs for economic development, sustainability and community projects. In general, city officials have said the four ...

Earlier this year, it was reported YouTube was very much aware its platform was plagued by fake movie trailers, often for films that didn’t have actual trailers of their own. Created or marketed with ...

License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ingredient (API) developed by TAPI and covered by TAPI patent applications ...

MOUNT PLEASANT, S.C. (WCBD) — A new program in Mount Pleasant is designed to make police encounters safer for people with communication difficulties. The Mount Pleasant Police Department is rolling ...

The 2-mile-long Forest Hill Flyover removes daily conflicts between 35 freight trains and 30 passenger trains in Chicago. November 21, 2025 After two decades, the Chicago Region Environmental and ...

Cequence Security, a pioneer in application and API security, announced the expansion and formalization of its Partner Program, further reinforcing the company’s commitment to a channel-only business ...

What if creating stunning, professional-grade videos was as simple as typing a few words or uploading an image? At OpenAI DevDay 2025, the unveiling of the Sora 2 API promised to transform the way we ...

Earlier in his career, Sam Feist ran a news program called “Crossfire” that tried to capture viewership by having liberals and conservatives bicker with one another. Now he hopes to achieve similar ...

Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the ...